Periodic Reporting for period 1 - PULTAR (Delivery of PULmonary Therapeutics through TARgetted Delivery using Phononics)

The cost of treating patients globally with all forms of lung disease is €380B p.a, leading to the loss of >50M DALYS. Generally, patients with such respiratory diseases can be treated by the inhalation of aerosols, where the therapy (including medicine or biologics used in...